These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26092313)

  • 1. How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease?
    Bannon D; Landau AM; Doudet DJ
    Curr Neurol Neurosci Rep; 2015 Aug; 15(8):53. PubMed ID: 26092313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Imaging Markers for Movement Disorders.
    Ghadery C; Strafella AP
    Curr Neurol Neurosci Rep; 2018 Apr; 18(5):22. PubMed ID: 29616343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging in Parkinson's disease.
    Au WL; Adams JR; Troiano A; Stoessl AJ
    J Neural Transm Suppl; 2006; (70):241-8. PubMed ID: 17017536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-photon emission computed tomography and positron emission tomography evaluations of patients with central motor disorders.
    Seibyl JP
    Semin Nucl Med; 2008 Jul; 38(4):274-86. PubMed ID: 18514083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging and therapeutics in movement disorders.
    Eckert T; Eidelberg D
    NeuroRx; 2005 Apr; 2(2):361-71. PubMed ID: 15897956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Imaging Biomarkers for Postischaemic Neurovascular Remodelling.
    Gandhi R; Tsoumpas C
    Contrast Media Mol Imaging; 2019; 2019():3128529. PubMed ID: 30863220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into Parkinson's disease models and neurotoxicity using non-invasive imaging.
    Sánchez-Pernaute R; Brownell AL; Jenkins BG; Isacson O
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):251-6. PubMed ID: 15979668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Movement disorders: role of imaging in diagnosis.
    Mascalchi M; Vella A; Ceravolo R
    J Magn Reson Imaging; 2012 Feb; 35(2):239-56. PubMed ID: 22271273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs.
    Lillethorup TP; Glud AN; Alstrup AKO; Mikkelsen TW; Nielsen EH; Zaer H; Doudet DJ; Brooks DJ; Sørensen JCH; Orlowski D; Landau AM
    Exp Neurol; 2018 May; 303():142-152. PubMed ID: 29428213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on movement disorders: What optogenetics has to offer.
    Rossi MA; Calakos N; Yin HH
    Mov Disord; 2015 Apr; 30(5):624-31. PubMed ID: 25777796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional neuroimaging in movement disorders].
    Borbély K
    Orv Hetil; 2001 Oct; 142(43):2347-55. PubMed ID: 11760452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression.
    Stelter L; Amthauer H; Rexin A; Pinkernelle J; Schulz P; Michel R; Denecke T; Stiepani H; Hamm B; Wiedenmann B; Scholz A
    Neuroendocrinology; 2008; 87(4):233-42. PubMed ID: 18025811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive imaging of experimental lung fibrosis.
    Zhou Y; Chen H; Ambalavanan N; Liu G; Antony VB; Ding Q; Nath H; Eary JF; Thannickal VJ
    Am J Respir Cell Mol Biol; 2015 Jul; 53(1):8-13. PubMed ID: 25679265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically modified pig models for neurodegenerative disorders.
    Holm IE; Alstrup AK; Luo Y
    J Pathol; 2016 Jan; 238(2):267-87. PubMed ID: 26446984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milestones in magnetic resonance imaging and transcranial sonography of movement disorders.
    Berg D; Steinberger JD; Warren Olanow C; Naidich TP; Yousry TA
    Mov Disord; 2011 May; 26(6):979-92. PubMed ID: 21626543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity.
    Val-Laillet D; Aarts E; Weber B; Ferrari M; Quaresima V; Stoeckel LE; Alonso-Alonso M; Audette M; Malbert CH; Stice E
    Neuroimage Clin; 2015; 8():1-31. PubMed ID: 26110109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movement disorders.
    Stoessl AJ; Mckeown MJ
    Handb Clin Neurol; 2016; 136():957-69. PubMed ID: 27430452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging the Nonmotor Symptoms in Parkinson's Disease.
    Yousaf T; Wilson H; Politis M
    Int Rev Neurobiol; 2017; 133():179-257. PubMed ID: 28802921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications.
    Kuriakose R; Stoessl AJ
    Prog Brain Res; 2010; 184():177-92. PubMed ID: 20887875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.